Home-based leg dexterity training for knee osteoarthritis
Official title: Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis
Run by Steadman Philippon Research Institute · NCT07397806 · Data updated 2026-11-12
This study will test whether an at-home leg dexterity device can reduce pain and improve function for people aged 40–85 with knee osteoarthritis compared with wobble-board exercises.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 85 Years |
| Sex | All |
| Enrollment | 82 (estimated) |
| Sponsor | Steadman Philippon Research Institute Academic / other |
| Locations | 1 site (Vail, Colorado) |
| Status | Recruiting |
| Started | September 11, 2025 |
| Main results expected | May 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | February 9, 2026 |
| Trial ID | NCT07397806 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ambulatory adults aged 40–85 with Kellgren-Lawrence grade II–IV knee osteoarthritis, baseline target-knee pain of 3–10 on an 11-point scale, and the capacity to give informed consent are ideal candidates.
✕Probably not a fit
Patients who recently had or plan knee surgery, are non-ambulatory, or have medical conditions preventing safe use of home exercise devices are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will randomize 84 ambulatory adults with radiographic knee osteoarthritis (Kellgren-Lawrence grade II–IV) to 8 weeks of home-based leg dexterity training using a slender unstable spring system (42 participants) or to dose-matched wobble board exercises (42 participants), with longitudinal follow-up at the Steadman Philippon Research Institute. The trial is designed as a double-blind, dose-matched comparison focused on neuromuscular control and whole-body function. Primary outcomes are the WOMAC Pain subscale and the Single Limb Stance Test, while secondary outcomes include WOMAC stiffness and physical function subscales and the IKDC subjective score. The aim is to see if targeted proprioceptive and short-latency sensorimotor retraining produces greater pain relief and functional gains than commonly prescribed wobble-board exercises.
Why it matters
Potential benefit: If successful, the device could provide a safe at-home supplement that reduces knee pain and improves leg function, potentially delaying or reducing the need for surgical interventions.
How similar studies have gone: Proprioceptive and balance exercises such as wobble-board training have shown benefit in knee OA, but the specific leg dexterity spring device is novel and has not been widely tested in randomized trials.
Who can join: the full rules
Show full inclusion / exclusion criteria
INCLUSION CRITERIA: 1. Age 40 to 85 years 2. Ambulatory in home and community settings 3. History of knee osteoarthritis in one or both knees (Kellgren-Lawrence grade II-IV) 4. Baseline pain of 3-10 points on the target (i.e., more-affected) knee and a pain differential of at least -2 points on the contralateral knee as exhibited by the worst pain score for the previous week (on the 11-point Numeric Rating Scale, NRS/Visual Analog Scale VAS). 5. Capacity to personally give informed consent (consent via a legally authorized representative will not be accepted) and who are willing to comply with all study-related procedures and assessments EXCLUSION CRITERIA: 1. Previous or Planned Knee Surgeries, Procedures, and/or Treatments: 1. Planned surgery on either the contralateral or target knee at any time during the Study period, including pre-and post-training assessments. 2. Within 6 months of signing informed consent has received diagnostic arthroscopy of the target knee or arthroscopic surgery (including microfracture and meniscectomy) on the target knee; 3. Within 12 weeks of signing informed consent has received intra-articular treatment of the target knee with steroids or hyaluronic acid derivatives; 4. Planned intra-articular treatment of the target knee with steroids or hyaluronic acid derivatives on either the contralateral or target knee at any time during the Study period including pre-and post-training assessments. 5. History of previous total or partial arthroplasty in the target knee. Partial or total arthroplasty in the contralateral knee is acceptable as long as the surgery was performed at least 6 months prior to enrollment and the operative knee is asymptomatic 2. Current and/or Previous Medical Conditions, Surgeries, and/or Procedures: 1. Within 2 years of signing informed consent, history of active blood disorders (i.e., DVTs, chronic blood clotting, hemophilia, leukemia, myeloma, etc.); or active malignancy of any type or history of a malignancy (with the exception of subjects with a history of treated basal or squamous cell carcinoma). 2. Current diagnosis of fibromyalgia based on American College of Rheumatology (ACR) criteria. 3. Any active known or suspected systemic autoimmune disease (except for vitiligo, residual auto-immune hypothyroidism requiring hormone replacement only, psoriasis not requiring systemic treatment for two years, conditions not expected to recur in the absence of an external trigger) or any history of systemic inflammatory arthritis such as psoriatic, rheumatoid, ankylosing spondylitis or reactive arthritis. 4. Current or prior history of other joint diseases including but not limited to joint dysplasia, crystal-induced arthropathy (such as gout, or calcium pyrophosphate deposition disease evidenced by clinical and/or radiographic means), aseptic osteonecrosis, acromegaly, Paget's disease, Ehlers-Danlos Syndrome, Gaucher's disease, Stickler syndrome, joint infection, hemochromatosis, or neuropathic arthropathy of any cause. 5. Any medical condition, including findings in laboratory or medical history or in the baseline assessments, that (in the opinion of the Principal Investigator or his designee) constitutes a risk or contraindication for participation in the Study or that could interfere with the Study conduct, endpoint evaluation or prevent the subject from fully participating in all aspects of the Study. 3. Within 8 weeks of signing informed consent, has used opioid analgesics and is not willing to discontinue these medications through the duration of the study.
Where it's running
-
Steadman Philippon Research Institute
Vail, Colorado, United States Recruiting
Study contacts
- Principal investigator: Scott Tashman, PhD — Steadman Philippon Research Institute
- Study coordinator: Sara Robinson, MS
- Email: srobinson@sprivail.org
- Phone: 970-401-8717
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can robotic-assisted knee replacement with functional alignment improve outcomes vs. standard knee replacement?
This trial tests whether using the VELYS robotic system during total knee replacement helps patients with knee osteoarthritis feel better and move more comfortably compared with conventional non-robotic surgery.
-
BETY with intra-articular injections for knee osteoarthritis
This will try whether adding BETY to intra-articular knee injections reduces pain and improves function in adults with stage 2 or 3 knee osteoarthritis.
-
Catheter embolization of small knee arteries to relieve osteoarthritis pain
This study will try using a catheter procedure to block small arteries around the knee to reduce chronic pain in adults 40–80 with knee osteoarthritis or persistent pain after knee replacement who haven't found enough relief from standard treatments.
-
Adding sensory nerve blocks to local pain injections for total knee replacement
This trial tests whether adding three sensory nerve blocks to standard local pain injections reduces pain and opioid use after primary unilateral total knee replacement.
-
Bimodal vs Unimodal High-Intensity Pulsed Electromagnetic Field Therapy for Older Adults with Knee Osteoarthritis
This trial will test whether applying high-intensity pulsed electromagnetic fields to both the knee and quadriceps reduces pain and improves function more than applying it only to the knee in adults 60 and older with knee osteoarthritis.
-
Methotrexate for knee osteoarthritis with ultrasound-proven synovitis
This randomized trial will try methotrexate versus placebo to see if it reduces pain and inflamed lining (synovitis) in people aged 40–70 with knee osteoarthritis confirmed by ultrasound.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.